Judith Cummins
MP for Bradford South · Labour · United Kingdom
“I thank the hon. Gentleman for notice of his point of order. I have received no notice from Ministers that they intend to make a statement on this matter. It is not a matter for the Chair, but Ministers on the Treasury Bench will have heard his point of order.”
House of Commons28 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“We come to the Select Committee statement on behalf of the Scottish Affairs Committee. Patricia Ferguson will speak for up to 10 minutes, during which time no interventions may be taken. At the conclusion of the statement, Members may ask questions on the subject of the statement. These should be brief questions, not speeches.”
House of Commons26 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“We come to the Select Committee statement on behalf of the Home Affairs Committee. Dame Karen Bradley will speak for up to 10 minutes, during which no interventions may be taken. At the conclusion of the statement, Members may ask questions on the subject of the statement. Those should be brief questions, not full speeches.”
House of Commons26 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“I thank the right hon. Gentleman for his point of order, and he can have his answer now. The Bill removes a disqualification from two categories of persons as set out in clause 1. The number of people who currently fall into those categories for the purposes of the Bill is not relevant to the test of hybridity.”
House of Commons21 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“I remind the House that this is a procedural motion. I encourage Members to focus their remarks on the issue of the carry-over extension. I remind the House that Mr Speaker granted an ongoing waiver to allow limited reference to active legal proceedings relating to historical troubles-related deaths.”
House of Commons13 October 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) The report under subsection (1)(b) must include— (a) an assessment of the current burden of musculoskeletal conditions in England including— (i) waiting times, (ii) emergency admissions or unplanned care, (iii) variation by integrated care board area, (iv) impact on work and economic inactivity, (v) outcomes, (b) the evidence of poten…”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
The complete record
2,594 lines on record for Judith Cummins, in date order, each linked to its source. Free to read, without an account. Most recent 500 lines shown. Search to find more. Page 2 of 10.
This is not an official version of UK Parliament proceedings. It reproduces the published record and links to it; the official version is the one UK Parliament publishes.
“New clause 143— Single sex facilities — “(1) The Secretary of State is required to ensure that there are single sex— (a) changing rooms for NHS staff, (b) toilets and washing facilities for NHS staff, (c) wards for NHS patients, and (d) toilets and washing facilities for NHS patients. (2) The Secretary of State may make exemptions to the duty in subsection (1)(c) and (1)(d) where necessary for— (a) children, (b) intensive care units, (c) critical care, and (d) specialist high observation areas such as resuscitation in Accident and Emergency and the initial recovery area in theatres.” This new clause creates a requirement for the Secretary of State to ensure certain single sex facilities are made available for NHS staff and patients. It provides exemptions in certain circumstances.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) For the purposes of this section, puberty blockers means— (a) a “gonadotrophin-releasing hormone (“GnRH”) analogue” which means a medicinal product that consists of or contains buserelin, gonadorelin, goserelin, leuprorelin acetate, nafarelin or triptorelin, and (b) any other drug which has the effect of suppressing or delaying puberty that the Secretary of State may by regulation appoint.” This new clause would create a requirement for the Secretary of State to make regulations which prevent puberty blockers from being prescribed to persons under 18 years of age for the purposes of treatment related to gender incongruence, or being given in clinical trials related to gender incongruence unless specifically approved by Parliament.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) Regulations under this section must ensure that such drugs cannot be given out or used as part of clinical trials for the treatment of gender dysphoria, gender incongruence or a combination of both, unless that trial has specifically been approved by a resolution of both Houses of Parliament.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) The conditions are that— (a) the Health Services Safety Investigations Body (or, if its functions have already been transferred under section 63 of this Act, the Care Quality Commission exercising those functions) has laid its final report on Advice and Guidance services before Parliament, and (b) the Secretary of State has published a written mitigation plan addressing the patient safety risks, harms and recommendations identified in that report (including any linked to patient deaths, near misses, treatment delays, resource and capacity gaps, workforce training, digital systems and incident reporting).” New clause 142— Puberty blockers — “(1) Within three months of the passage of this Act the Secretary of State must make regulations which ensure that puberty blockers may not be prescribed, dispensed or supplied to persons under 18 years of age for the purposes of treatment related to gender dysphoria, gender incongruence or a combination of both, in the United Kingdom.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(5) The inquiry under subsection (2) must be published and laid before Parliament as a final report within 6 months beginning on the day on which the inquiry is established.” This new clause places a duty on the Secretary of State to end Corridor Care within 12 months, if they fail to do so they must order an independent inquiry into corridor care and the failure to eradicate the practice. New clause 141— Suspension of Advice and Guidance pending HSSIB report and mitigation plan — “(1) The Secretary of State must ensure that the operation and further rollout of Advice and Guidance services (including any targets, incentives, pathways or contractual requirements that treat Advice and Guidance as a prerequisite or preferred alternative to direct referral) are suspended until the conditions in subsection (2) are met.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) If the requirement under subsection (1) is not met, the Secretary of State must commission an independent inquiry into the Government's handling of corridor care. (3) The inquiry under subsection (2) must— (a) investigate the effectiveness of policies, funding and guidance relating to corridor care in the Department of Health and Social Care; (b) assess the impact on patient safety and staff morale from the continued practice of corridor care; and (c) recommend steps the Secretary of State should take to end the practice of corridor care. (4) The inquiry under subsection (2) should be supported by patient safety professionals from the Health Services Safety Investigations Body and the Care Quality Commission.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(4) The Secretary of State must, within 12 months of this section coming into force, publish guidance for integrated care boards and fire and rescue authorities on the operation of this section. (5) In this section, “fire and rescue authority” has the meaning given by section 1 of the Fire and Rescue Services Act 2004.” This new clause would place a duty on integrated care boards to share relevant data concerning vulnerable residents with fire and rescue authorities, subject to data protection safeguards, to enable fire and rescue services to identify and prioritise vulnerable people in emergencies, including fires and flooding. New clause 140— Corridor care — “(1) The Secretary of State must end the practice of corridor care in NHS hospitals within one year of the passage of this Act.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) In this section, “relevant data” means data relating to a person’s vulnerability, including but not limited to age, disability or mobility, that is necessary and proportionate for the purpose in subsection (1). (3) Data may only be shared under this section— (a) in accordance with the requirements of the UK GDPR and the Data Protection Act 2018; (b) subject to arrangements agreed between the integrated care board and the fire and rescue authority setting out the purpose, extent and security of the data sharing; and (c) where a mechanism exists for a person to object to the sharing of their data under this section, save where doing so would be likely to endanger life.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) The Secretary of State must lay a copy of the report before Parliament.” This new clause would require the Secretary of State to report on occupational health screening, including blood testing, for fire and rescue personnel, in recognition of their elevated risk of cancer arising from occupational exposure to carcinogens. New clause 139— Duty on integrated care boards to share data with fire and rescue authorities concerning vulnerable persons — “(1) An integrated care board must take reasonable steps to share, or to facilitate the sharing of, relevant data with a fire and rescue authority for the area, or part of the area, for which the integrated care board has responsibility, for the purpose of enabling the fire and rescue authority to identify and prioritise vulnerable persons in the event of an emergency.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) The report under subsection (1) must consider— (a) the classification by the International Agency for Research on Cancer of occupational exposure as a firefighter as carcinogenic to humans; (b) the current provision of occupational health screening for fire and rescue personnel by fire and rescue authorities, NHS bodies and integrated care boards; (c) options for a national baseline entitlement to periodic health screening for fire and rescue personnel, informed by exposure risk; (d) the resource and workforce implications of any such entitlement; and (e) the interaction of any such entitlement with existing work by the Fire Brigades Union and the University of Central Lancashire on the UK Firefighters Cancer and Disease Registry.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“The Health Bill removes this provision. This new clause would place a new duty on the Secretary of State to prioritise cancer outcomes such as survival by inserting a new section into Part 1 of the National Health Service Act 2006. New clause 138— Report on occupational health screening for fire and rescue personnel — (1) The Secretary of State must, within 12 months of the passing of this Act, publish a report on access to occupational health screening, including blood testing for biomarkers of exposure to carcinogens, for members of fire and rescue services in England.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) Regulations under this section are subject to the affirmative procedure.” This new clause would require the Secretary of State to introduce regulation of non-therapeutic male circumcision, following several prevention of future death reports issued by coroners as a result of deaths arising from this procedure. New clause 137— Cancer outcomes — “(1) The National Health Service Act 2006 is amended as follows. (2) After section 1GA insert— “1GB Cancer outcomes In exercising functions relating to the health service, the Secretary of State must treat objectives relating to cancer outcomes as having priority over any other objectives relating specifically to cancer.”” The Secretary of State is currently required to set cancer outcome objectives for NHS England, with those objectives taking priority over other cancer goals.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) Regulations made under subsection (1) must make provision for— (a) a requirement that NTMC may only be performed by a suitably qualified healthcare professional and must be inspected by the Care Quality Commission; (b) the inclusion of NTMC as a regulated activity under the Health and Social Care Act 2008; (c) the creation of a statutory duty for integrated care boards to produce annual data on prevalence and complications of NTMC; (d) a requirement that NTMC be included in the Single Patient Record; and (e) any other matter that the Secretary of State deems appropriate.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) Regulations made under this section are subject to the affirmative procedure.” This new clause would require the Secretary of State to make regulations governing the activities of religious groups in medical settings in England, to prevent medical coercion. New clause 132— Non-therapeutic male circumcision — “(1) The Secretary of State must, within six months of the passage of this Act, make regulations relating to non-therapeutic male circumcision (NTMC).”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) Regulations made under subsection (1) must make provision for— (a) clinical oversight of training provided by representatives of religious groups to healthcare professionals and students on the treatment of patients who hold religious beliefs that may influence their choice of treatment; (b) ensuring that the contacting of any religious group on behalf of a patient, or for advice on care, is made only at the request of the patient; (c) requiring opportunities for patients to indicate final treatment preference in the absence of religious representatives, and ensuring religious representatives cannot later verify a patient’s final treatment choice; and (d) any other matter that the Secretary of State deems appropriate.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) Any Health and Social Care body that fails to meet the requirement set out in subsection (2) must— (a) publish an explanation of the reasons for the failure; (b) specify any circumstances which have prevented implementation; and (c) publish a plan setting out the steps it will take to implement the recommendation. (4) Regulations under this section are subject to the affirmative procedure.” New clause 131— Activities of religious groups in medical settings — “(1) The Secretary of State must, within six months of the passage of this Act, make regulations concerning the activities of religious groups in medical settings in England.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(4) The Secretary of State must publish a further report reviewing progress against the strategy within eighteen months beginning on the day on which this Act is passed.” This new clause would require the Secretary of State to publish a strategy to address waiting times and geographical inequality in access to NHS speech and language therapy, and to report on progress against that strategy. New clause 123— NICE technology appraisal recommendation: accountability scheme — “(1) The Secretary of State must establish by regulations an accountability scheme relating to the implementation of NICE technology appraisal recommendations (the "scheme"). (2) Under the scheme, Health and Social Care bodies must take all reasonable steps to implement a NICE technology appraisal recommendation within three months of receiving such a recommendation.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 117— Access to speech and language therapy — “(1) The Secretary of State must, within six months beginning on the day on which this Act is passed, publish a strategy for improving access to NHS speech and language therapy services in England. (2) The strategy under subsection (1) must include— (a) an assessment of waiting times for speech and language therapy across integrated care boards; (b) an assessment of variation in access to speech and language therapy between different areas of England; (c) an assessment of the speech and language therapy workforce, including current vacancy rates and future workforce need; and (d) proposals to reduce waiting times and geographical variation in access. (3) The Secretary of State must lay a copy of the strategy before Parliament.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) The Secretary of State must take reasonable steps to support and facilitate clinical trials into the use of medicinal cannabis for children, with the aim of establishing a clearer evidence base to inform NHS prescribing guidance. (4) The Secretary of State must lay a copy of the review before both Houses.” This new clause would require the Secretary of State to review inconsistencies in NHS access to medicinal cannabis for children, including the extent to which patients are forced to rely on private prescriptions, and would place a duty on the Secretary of State to support clinical trials to strengthen the evidence base for prescribing.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 116— Access to medicinal cannabis for children: review and clinical trials — “(1) The Secretary of State must, within six months beginning on the day on which this Act is passed, publish a review on access to medicinal cannabis for children on the NHS. (2) The review under subsection (1) must consider— (a) variation between integrated care boards in the referral and prescribing of medicinal cannabis to children; (b) the barriers preventing children from accessing medicinal cannabis through the NHS, including the number of patients who access private prescriptions as a result; (c) the current evidence base for the clinical effectiveness of medicinal cannabis for children; and (d) options for expanding that evidence base through clinical trials.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) In conducting the review, the Secretary of State must consult persons with clinical, technical, operational and patient expertise in radiotherapy services. (4) The Secretary of State must lay the review before Parliament and set out any steps proposed to address identified gaps in access to radiotherapy services or waiting times for radiotherapy. (5) In this section, “radiotherapy services” means services involving the use of ionising radiation for the treatment of cancer.” This new clause would require the Secretary of State to review access to radiotherapy services and radiotherapy waiting times. The review would examine variation between ICB areas, delays where radiotherapy is a first or subsequent treatment, and the capacity constraints affecting patient access.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 114— Radiotherapy services: access and waiting times — “(1) Within six months of the passing of this Act, the Secretary of State must conduct and publish a review of access to radiotherapy services and waiting times for radiotherapy in England. (2) The review must include an assessment of— (a) variation in access to radiotherapy services between integrated care board areas; (b) waiting times for radiotherapy services, including where radiotherapy is the first, second or subsequent cancer treatment received by a patient; and (c) the extent to which capacity, equipment, workforce or investment constraints are affecting access to radiotherapy services or waiting times for radiotherapy.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(6) The Secretary of State must lay before Parliament, at least once in each financial year, a report on the implementation of the framework and any steps proposed to address underperformance or unwarranted variation. (7) In this section, “radiotherapy services” means services involving the use of ionising radiation for the treatment of cancer.” This new clause would require the Secretary of State to publish a national framework for improving access to radiotherapy services. Integrated Care Boards would be required to report annually against national metrics on waiting times, access, equipment, capacity, workforce, investment and variation.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) The metrics must include, but are not limited to, metrics relating to— (a) waiting times for radiotherapy; (b) access to radiotherapy services, including variation in radiotherapy treatment rates between integrated care board areas; (c) the age, capability and replacement needs of radiotherapy equipment; (d) radiotherapy capacity against assessed population need; and (e) workforce capacity. (4) Each integrated care board must publish an annual report on its performance against the metrics in the framework. (5) Before publishing or revising the framework, the Secretary of State must consult persons with clinical, technical, operational and patient expertise in radiotherapy services.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(5) The first review under this section must be completed within 12 months of the passing of this Act and subsequent reviews must be completed at intervals of not more than five years.” This new clause would require a national review of CAMHS provision in rural areas, including access, waiting times, workforce capacity and the availability of community-based services. New clause 113— Radiotherapy services: access and accountability — (1) The Secretary of State must publish and maintain a national framework for improving access to radiotherapy services in England. (2) The framework must set out nationally agreed metrics against which integrated care boards must measure and report their delivery of, and investment in, radiotherapy services.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) Any review must consider— (a) waiting times for assessment and treatment; (b) access to interim support following referral; (c) travel distances and access to public transport; (d) staffing and specialist service capacity; (e) the availability of community-based provision; and (f) the use of vacant or underused public buildings for the delivery of services. (3) A review must identify areas where the provision of child and adolescent mental health services is insufficient to meet local need. (4) The Secretary of State must publish the findings of any review and an action plan setting out measures to address any significant deficiencies identified.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(4) In preparing the plan, an integrated care board must have regard to— (a) the number of children and young people receiving CAMHS services; (b) waiting times for assessment and treatment; (c) the number and complexity of cases managed by individual staff members; and (d) the availability of specialist clinical services.” This new clause would require integrated care boards to assess and address staffing and service capacity in CAMHS, including access to appropriate specialist services. New clause 112— Review of child and adolescent mental health services in rural areas — “(1) The Secretary of State must conduct, or arrange for the conduct of, reviews of the provision of child and adolescent mental health services in rural areas in England.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) Where an assessment under subsection (1) identifies a significant shortfall, the integrated care board must prepare and implement a plan to address that shortfall. (3) The plan must include measures to support the recruitment and retention of suitably qualified staff and, where clinically appropriate, the provision of specialist services including trauma assessment, dialectical behaviour therapy and art therapy.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(4) An integrated care board and a local authority may make arrangements for the use or repurposing of vacant or underused public buildings for the provision of child and adolescent mental health services.” This new clause would improve access to CAMHS in rural areas by supporting locally delivered services and enabling vacant or underused public buildings to be repurposed for community mental health provision. New clause 111— Child and adolescent mental health workforce and service capacity — “(1) Each integrated care board must assess whether child and adolescent mental health services in its area have sufficient staffing and clinical capacity to meet the needs of children and young people.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) In exercising its functions under subsection (1), an integrated care board must have regard to— (a) travel distances and travel times; (b) the availability of public transport; (c) the availability of locally accessible community facilities; and (d) the particular needs of children and young people who may face barriers to travelling to a centralised service. (3) The Secretary of State must provide appropriate support to integrated care boards and local authorities to develop community-based child and adolescent mental health services in rural areas.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) The Secretary of State must make a statement to Parliament each year, until 2030, setting out progress towards universal access to fracture liaison services.” This new clause would require the Secretary of State to publish an implementation framework for ensuring universal access to fracture liaison services in England by 2030. New clause 110— Rural access to child and adolescent mental health services — “(1) Each integrated care board must make arrangements to ensure that children and young people in rural areas have reasonable access to child and adolescent mental health services.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) The framework must set out— (a) the minimum standards expected of fracture liaison services; (b) the steps to be taken to reduce unwarranted variation in access and quality between integrated care board areas; (c) the respective responsibilities of integrated care boards and NHS trusts; (d) the workforce, diagnostic, digital and data requirements necessary to support implementation; and (e) arrangements for identifying people at risk of further fragility fractures and ensuring that they receive appropriate assessment, treatment and follow-up.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) Guidance issued under subsection (1) must have regard to Article 2 of the European Convention on Human Rights.” This new clause would require the Secretary of State to issue guidance to integrated care boards concerning their role in communicating with parents of critically ill children, and involving them in decision-making. New clause 107— Fracture liaison services: implementation framework — “(1) The Secretary of State must, within six months of the passing of this Act, publish an implementation framework for ensuring universal access to fracture liaison services in England by 2030.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) Guidance issued under subsection (1) must— (a) make provision for ensuring that parents have been fully consulted and are fully informed of decisions concerning the care or treatment of their child and the rationale behind such decisions; (b) make provision, where potentially life-ending or life-changing decisions are to be made, to facilitate parents in accessing an independent specialist second opinion; (c) make provision, where there is a disagreement between parents and clinicians on the care or treatment of a child, for the appointment of an independent mediator; (d) make provision, following the advice of an independent specialist second opinion, for transfer of the child to another hospital, subject to appropriate clinical safeguards; (e) make provision, prior to the death of a child, for family members to be given access to the child, whether in the hospital, a children’s hospice or the family home.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 103— Communication with parents of critically ill children — “(1) The Secretary of State must, within 12 months of the passing of this Act, issue guidance to integrated care boards on communication with parents of critically ill children, with particular reference to major decisions in the child’s treatment and care.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 102— Report on impact on health of social media addiction — “(1) The Secretary of State must, within six months of the passage of this Act, commission a report on the impact on health of social media addiction. (2) The report under subsection (1) must consider and make recommendations concerning— (a) the mental health effects of social media addiction; (b) the physical health effects of social media addiction; and (c) the effects of social media addiction on demand for NHS services. (3) The Secretary of State must lay a copy of the report with proposed actions to minimise the health harms of social media addiction before both Houses of Parliament.” This new clause would require the Secretary of State to commission a report considering the impact on health of social media addiction.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) The report under subsection (1) must investigate regulatory measures regarding professional checks on the providers of cosmetic surgery, including whether they— (a) are registered medical practitioners; (b) have completed recognised specialist surgical training; and (c) hold Cosmetic Surgery Board Certification, or an equivalent certification, accreditation or qualification. (3) The report must also consider the safety of current regulations of the premises where cosmetic surgery procedures are undertaken.” This new clause would require the Secretary of State to prepare a report assessing the regulation of cosmetic surgery.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(4) The Secretary of State must publish the outcome of the review in subsection (1).” This new clause requires the Secretary of State to review whether hospitals experiencing significant estate failure are being appropriately prioritised within the New Hospital Programme, and to ensure that such hospitals are treated with the same urgency as RAAC-affected hospitals. New clause 92— Duty to report on the regulation of cosmetic surgery — “(1) Within three months of the passing of this Act, the Secretary of State must publish a report assessing the effectiveness and safety of current regulation of cosmetic surgery.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 89— New Hospital Programme: estate failure — “(1) Within six months beginning on the date on which this Act is passed, the Secretary of State must review whether hospitals experiencing significant estate failure are being appropriately prioritised within the New Hospital Programme. (2) For the purposes of subsection (1), “significant estate failure” includes the closure, partial closure or restricted use of hospital buildings because of structural, safety or infrastructure failures. (3) In prioritising schemes within the New Hospital Programme, the Secretary of State must ensure that hospitals experiencing significant estate failure are treated with the same urgency as hospitals affected by reinforced autoclaved aerated concrete.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) The Secretary of State may redact information published under this section where publication would— (a) prejudice commercial negotiations, (b) disclose personal data, or (c) endanger the safety or security of patients, staff or NHS premises. (4) Where information is redacted under subsection (3), the Secretary of State must publish a statement explaining the reason for the redaction. (5) The Secretary of State must lay the reports and information published under this section before Parliament.” This new clause requires the Secretary of State to publish the criteria, input data and scoring mechanism used to determine the prioritisation of schemes and their allocation to waves within the New Hospital Programme. Whilst the input data was obtained from publicly available sources, the MCDA reports are currently not publicly available.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) The information published under subsection (1) must include— (a) the multi-criteria decision support analysis tool used to prioritise schemes; (b) the input data used in that analysis for each hospital in the New Hospital Programme; (c) the scoring mechanism used in that analysis; (d) any assessment of estate condition, including data from the NHS England Estate Return Information Collection; (e) any assessment of patient safety, service disruption or maintenance backlog; (f) any assessment of the presence of reinforced autoclaved aerated concrete; (g) any assessment of the risks associated with delaying individual schemes; and (h) any review of the appropriateness of the input data or scoring mechanism by NHS England or the Department of Health and Social Care.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 88— New Hospital Programme: publication of multi-criteria decision analysis (MCDA) reports — “(1) Within three months beginning on the date on which this Act is passed, the Secretary of State must publish the MCDA reports used to determine the prioritisation of schemes and their allocation to waves within the New Hospital Programme.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(3) Provision under subsection (2) applies to— (a) approved research bodies, (b) authorised researchers, and (c) participating healthcare providers, and specified substances used for approved research purposes, and does not alter the schedule or classification of a substance. (4) Regulations under this section are to be made by statutory instrument subject to the affirmative procedure.” This new clause would require the Secretary of State to take steps to enable and support the development of research relating to innovative treatments, which use substances listed in Schedule 1 of the Misuse of Drugs Regulations 2001.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) Regulations made under this section must make provision, for— (a) the lawful possession, supply, administration, production and importation of such substances for the purposes of clinical trials or other research activities approved in accordance with regulations made by the Secretary of State, notwithstanding any prohibition or restriction imposed by or under the Misuse of Drugs Act 1971 or the Misuse of Drugs Regulations 2001; and (b) proportionate and timely arrangements relating to the approval, licensing and oversight of authorised research activities under this section.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(4) Regulations under this section are to be made by statutory instrument subject to the affirmative procedure.” This new clause would require the Secretary of State to make provision for compassionate access to innovative treatments, involving substances listed in Schedule 1 of the Misuse of Drugs Regulations 2001, for patients with serious or life-threatening conditions in certain circumstances. New clause 87— Research into innovative treatments involving controlled substances — “(1) The Secretary of State must by regulations take steps to enable and support the development of research relating to innovative treatments, which use substances listed in Schedule 1 of the Misuse of Drugs Regulations 2001.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) Regulations made under this section must make provision for the authorisation, supply, possession, administration and supervision of such treatments, notwithstanding any restriction imposed by or under the Misuse of Drugs Act 1971 or the Misuse of Drugs Regulations 2001, including provision for— (a) appropriate clinical and regulatory safeguards; (b) approval arrangements for participating clinicians, providers and pharmacies; and (c) case-by-case decision-making having regard to clinical need, patient safety, and available evidence. (3) For the purposes of this section, a serious or life-threatening condition is defined as a condition involving a substantial risk to life or serious impairment of health or functioning.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 86— Compassionate access to innovative treatments — “(1) In exercising their functions in relation to the health service, the Secretary of State must by regulations make provision for compassionate access to innovative treatments, involving substances listed in Schedule 1 of the Misuse of Drugs Regulations 2001, for patients with serious or life-threatening conditions in circumstances where conventional treatments have been unsuccessful, unsuitable, or unavailable.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(4) The outcome of any discussion held under subsection (2), including the views expressed by the child's parent, guardian or primary carer, must be recorded in the child's medical records. (5) NHS England must publish guidance on the operation of this section, including circumstances in which further imaging should be considered following uncertain or indeterminate findings.” This new clause requires consultant review of uncertain imaging findings in children with designated high-risk conditions. It also aims to ensure that parents are informed of the uncertainty, the available options and the risks and benefits of those options before a decision is made.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“(2) Following such a review, the responsible NHS provider must ensure that the child's parent, guardian or primary carer is informed— (a) of the nature of the uncertainty identified; (b) whether disease progression, relapse or recurrence can be confidently excluded; (c) what further investigations or surveillance are being considered; and (d) the risks and benefits associated with immediate further imaging, alternative imaging modalities, or continued observation. (3) Where disease progression or relapse cannot be confidently excluded, the responsible NHS provider must consider whether additional imaging or investigation should be undertaken within 14 days or as soon as clinically practicable, whichever is sooner.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗
“New clause 83— Review of uncertain imaging findings in high-risk childhood illness — “(1) Where imaging undertaken in relation to a child with a high-risk cancer or other life-threatening condition identifies findings that are— (a) inconclusive, (b) indeterminate, or (c) suspicious, the responsible NHS provider must ensure that the findings are reviewed by a consultant clinician responsible for the child's care.”
House of Commons8 September 2026Contains Parliamentary information licensed under the Open Parliament Licence v3.0Source ↗